Correlates of p53- and Fas (CD95)-mediated apoptosis in Alzheimer's disease.
about
LFG: an anti-apoptotic gene that provides protection from Fas-mediated cell deathLifeguard/neuronal membrane protein 35 regulates Fas ligand-mediated apoptosis in neurons via microdomain recruitmentDown-regulation of WW domain-containing oxidoreductase induces Tau phosphorylation in vitro. A potential role in Alzheimer's diseaseIncreased APLP1 expression and neurodegeneration in the frontal cortex of manganese-exposed non-human primatesAPLP1, Alzheimer's-like pathology and neurodegeneration in the frontal cortex of manganese-exposed non-human primatesGene therapy for brain cancer: combination therapies provide enhanced efficacy and safety.Role of aberrant nitric oxide synthase-3 expression in cerebrovascular degeneration and vascular-mediated injury in Alzheimer's disease.Alzheimer's disease is type 3 diabetes-evidence reviewed.Oxidatively modified glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and Alzheimer's disease: many pathways to neurodegenerationTransient axonal glycoprotein-1 induces apoptosis-related gene expression without triggering apoptosis in U251 glioma cellsNeuronal life and death: an essential role for the p53 family.Structure and pathology of tau protein in Alzheimer disease.Cell cycle checkpoint abnormalities during dementia: A plausible association with the loss of protection against oxidative stress in Alzheimer's disease [corrected].The p53 homologue p73 accumulates in the nucleus and localizes to neurites and neurofibrillary tangles in Alzheimer disease brain.Soluble beta-amyloid peptides, but not insoluble fibrils, have specific effect on neuronal microRNA expression.Transcription factor p53 influences microglial activation phenotypeAssembly and interrogation of Alzheimer's disease genetic networks reveal novel regulators of progressionElevated levels of pro-apoptotic p53 and its oxidative modification by the lipid peroxidation product, HNE, in brain from subjects with amnestic mild cognitive impairment and Alzheimer's disease.Relationship between the FAS gene A-670G polymorphism and Alzheimer's disease: a meta-analysis.Complex regulation of p73 isoforms after alteration of amyloid precursor polypeptide (APP) function and DNA damage in neurons.Mitochondria and cell bioenergetics: increasingly recognized components and a possible etiologic cause of Alzheimer's disease.DNA damage responses in neural cells: Focus on the telomereAmyloid-beta peptide induces oligodendrocyte death by activating the neutral sphingomyelinase-ceramide pathway.Selective cytotoxicity of intracellular amyloid beta peptide1-42 through p53 and Bax in cultured primary human neurons.Nitric oxide mediates glial-induced neurodegeneration in Alexander diseaseThe p53 family in nervous system development and disease.Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses.Transcriptional activator TAp63 is upregulated in muscular atrophy during ALS and induces the pro-atrophic ubiquitin ligase Trim63.Altered distribution of cell cycle transcriptional regulators during Alzheimer disease.No more brain tangles with DeltaNp73.Molecular regulation of DNA damage-induced apoptosis in neurons of cerebral cortex.Discover the network mechanisms underlying the connections between aging and age-related diseases.Release of HMGB1 in response to proapoptotic glioma killing strategies: efficacy and neurotoxicity.p53-dependent Fas expression is critical for Ginsenoside Rh2 triggered caspase-8 activation in HeLa cells.Decreased cortical FADD protein is associated with clinical dementia and cognitive decline in an elderly community sample.p53-targeted cancer pharmacotherapy: move towards small molecule compounds.Genetic determinants of neuronal vulnerability to apoptosis.Link between cancer and Alzheimer disease via oxidative stress induced by nitric oxide-dependent mitochondrial DNA overproliferation and deletionThe catalytic subunit of telomerase protects neurons against amyloid beta-peptide-induced apoptosis.p53 functional inhibitors behaving like pifithrin-β counteract the Alzheimer peptide non-β-amyloid component effects in human SH-SY5Y cells.
P2860
Q22010722-43FD3373-3E09-4EBF-BD31-C1B036114799Q24319929-324EDBBC-AB55-4131-8AD8-ACA1DBDC0B79Q28260248-1F03A669-832A-47F0-A293-E18E117FB93FQ28388232-10A32FC9-0A41-4941-83B8-5CF76EBFA15FQ28396938-FEA7C4B5-954F-47EB-A2F5-411CA6CA94C2Q33828114-091552E4-5982-47F9-94A3-DCDF6E3BC549Q33922669-5B5BE829-2FAB-49BA-A2EE-3510B91838FAQ34020000-3FD51C52-A82D-4673-A681-4644EA19FE8DQ34071097-5179723A-C35B-4430-90DE-5DEBDA31A982Q34128088-F45A86B6-357A-4C22-9535-AD0AAE9E50E1Q34201997-363B745C-BA35-40C8-A092-4756405D81B5Q34280787-115DE6DD-D224-47E2-BC4B-196541BDA43DQ34827354-A7267286-4A55-46FB-B9E1-43E9C90B0DA5Q34977205-A821960D-270C-42E2-BB5B-D92CE1512CE2Q35111407-01251006-5969-4402-A32A-327159BB3ACCQ35127007-4B833CC3-6684-4777-BD56-864187E5ACDAQ35188314-DB7E54DD-28CC-4142-8844-0A2C6B0F1349Q35458379-7477E351-E232-467A-85E4-6091A3126DE2Q35586831-D5D06235-5216-4F08-B1D2-93EA8D66BD83Q35604588-2CC204EF-79B6-43D3-B1DB-DB0B78ED1CCEQ35898628-F47CCCE1-F88D-4550-8EC3-E416F869E4F5Q35900920-5AB9936B-1287-449A-ADC9-AF16F4183BA5Q36321788-94E6804B-D2DB-4DD9-8FC9-D819D81DDF0EQ36324215-FE8902C3-9C19-403C-8708-C955369EE926Q36360991-69F1B034-0AF3-41FF-917D-2ED04A2F6FE3Q36521923-7AE6FB29-62F3-491E-97DC-3773D09609C6Q36605276-7355C5AD-A05C-41DC-983C-B82D86C52AFDQ36673695-3D545849-3470-48DA-B9A6-B3833B6D775BQ36931808-61B4F481-5CD8-4BCC-BE76-90FB2B4A042CQ37060482-FA2FA5CF-A6AC-4F97-96F4-F4CE75062989Q37180866-A9806BC8-0DA7-4BDA-AEC8-F978641DADF7Q37223813-771F5D8A-2B5C-496D-AD5F-630023C65209Q37403279-D13F72B7-762B-4D5A-813F-03DAD0407AE0Q37666453-9B83C5AD-1240-4DCF-9FDE-E76248A755CDQ37713734-E1320F77-5539-4F52-A960-3EDEE87D69A2Q37865050-3DE9ADD7-1352-4A84-A7EF-046306372D3EQ38018496-280F6FD8-CC7F-4128-93F5-786A916A7D20Q38108308-D6E97FED-CF39-4AC7-B64A-32CC2E21C24EQ38311394-9B5DC0D1-3226-4F63-A0D2-37C41CCA59CEQ39013934-B1CA1CE4-1AE8-48A5-B2EA-BABE63E12D09
P2860
Correlates of p53- and Fas (CD95)-mediated apoptosis in Alzheimer's disease.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Correlates of p53- and Fas (CD95)-mediated apoptosis in Alzheimer's disease.
@en
Correlates of p53- and Fas
@nl
type
label
Correlates of p53- and Fas (CD95)-mediated apoptosis in Alzheimer's disease.
@en
Correlates of p53- and Fas
@nl
prefLabel
Correlates of p53- and Fas (CD95)-mediated apoptosis in Alzheimer's disease.
@en
Correlates of p53- and Fas
@nl
P2093
P1476
Correlates of p53- and Fas (CD95)-mediated apoptosis in Alzheimer's disease.
@en
P2093
P356
10.1016/S0022-510X(97)00131-7
P577
1997-11-01T00:00:00Z